Vor Biopharma Inc.VORNASDAQ
LOADING
|||
Cash Flow Under Pressure
Below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-99.89M
↓ 66% below average
Average (6y)
$-60.23M
Historical baseline
Range
High:$-2.66M
Low:$-101.36M
CAGR
+83.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-99.89M | +1.5% |
| 2023 | $-101.36M | -8.3% |
| 2022 | $-93.61M | -28.2% |
| 2021 | $-73.04M | -80.6% |
| 2020 | $-40.45M | -281.5% |
| 2019 | $-10.60M | -298.5% |
| 2018 | $-2.66M | - |